Crowd tape
Reddit crowd sentimentTracked across the finance subredditsSee the dashboard for live mention data

Equity · Healthcare

AKTX

Akari Therapeutics, Plc · NasdaqCM

$10 +7.99% 1D Finazon · prior-day close · Sep 22, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$20 $5 25 Jun 22 Sep

The line runs $10 on 25 June through $10 on 22 September, on a scale from $5 to $20. Days the market did not trade hold the previous close, flat.

The chart above plots the price of AKTX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $10 on 25 June 2026 through $10 on 22 September 2026.

Market cap $1.44T
Avg volume 1.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 21, 2026

AKTX insider trades

SEC Form 4

AKTX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 November 2025.

Date Insider Type Shares Value
25 Aug 2025 Gaslightwala Abizer CEO Buy 3,000 $3K
22 Aug 2025 Gaslightwala Abizer CEO Buy 8,000 $7K
21 Aug 2025 Gaslightwala Abizer CEO Buy 10,000 $9K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Nov 2025 Farag Kameel D. Interim CFO Award 58,619 $44K
22 Oct 2025 Farag Kameel D. Interim CFO Award 6,277 $5K

AKTX reported financials

SEC EDGAR XBRL

AKTX reported net income of −$17.3M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$17.3M 31 Dec 2025 fiscal year
Diluted EPS $0.00 31 Dec 2025 fiscal year
Total assets $38.6M 30 Jun 2026 at period end
Total equity $18.6M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

AKTX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.00
31 Mar 2026 Q1 2026 $0.00
31 Dec 2025 FY 2025 $0.00
30 Sep 2025 Q3 2025 $0.00
30 Jun 2025 Q2 2025 $0.00
31 Mar 2025 Q1 2025 $0.00
31 Dec 2024 FY 2024 $0.00
30 Sep 2024 Q3 2024 $0.00

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AKTX institutional holders

SEC Form 13F

0 of the 45 institutional funds we track reported a AKTX position for the quarter ended 30 Sep 2025; the latest of those filings landed 13 Nov 2025.

Fund Action Shares Value

Source: SEC EDGAR 13F filings

AKTX fails-to-deliver

SEC CNS data

On 31 Aug 2026, 635 shares of AKTX failed to deliver (about $7K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Aug 2026 635 $7K <0.001%
28 Aug 2026 5,517 $49K <0.001%
27 Aug 2026 5,117 $47K <0.001%
19 Aug 2026 41 $315 <0.001%
18 Aug 2026 206 $2K <0.001%
17 Aug 2026 3,312 $25K <0.001%
10 Aug 2026 1,150 $8K <0.001%

Source: SEC fails-to-deliver (CNS) data